Episode Details

Back to Episodes
Pharmaceutical Executive Daily: FDA Approves Imaavy for wAIHA

Pharmaceutical Executive Daily: FDA Approves Imaavy for wAIHA

Published 2 months, 3 weeks ago
Description
FDA approves Imaavy as the first treatment for warm autoimmune hemolytic anemia, McKesson agrees to acquire Precision Medicine Group as Lundbeck partners with Eversana on AI-driven commercialization, and Adam Bartley examines how integrated GMP operating models are reshaping outsourced manufacturing.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us